Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.800 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	28,150
Open	6.800
Bid (Size)	6.750 (100)
Ask (Size)	6.780 (500)
Prev. Close	6.800
Today's Range	6.800 - 6.800
52wk Range	5.010 - 11.55
Shares Outstanding	74,484,166
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why I Wouldn't Touch Novavax With a 10-Foot Pole ↗

December 11, 2025

This stock could be a wealth destroyer in the next five years.

Via The Motley Fool

Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗

December 01, 2025

Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.

Via Investor's Business Daily

Performance

YTD	-20.7%	-20.7%
1 Month	+2.6%	+2.6%
3 Month	-21.6%	-21.6%
6 Month	+4.8%	+4.8%
1 Year	-21.3%	-21.3%

More News

Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale ↗

November 12, 2025

Via Stocktwits

Novavax Sees Higher Revenue From Partners For Full-Year, Raises Revenue Guidance ↗

November 06, 2025

Via Stocktwits

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

An Overview of Novavax's Earnings ↗

November 05, 2025

Via Benzinga

Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda ↗

September 04, 2025

Via Stocktwits

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

Via Benzinga

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Via Benzinga

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential ↗

October 14, 2025

Via Benzinga

Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity ↗

October 14, 2025

Via Stocktwits

ConnectM Exits Nasdaq for OTCQB Venture Market: A Deep Dive into Delisting, Challenges, and a Path Forward

October 02, 2025

Via MarketMinute

India's Tech Ascent: A 'Mission Mode' for Global Leadership in Semiconductors, Quantum, AI, and Biomanufacturing

October 01, 2025

Via MarketMinute

Novavax Amends Deal With Sanofi, Broadens Partnership ↗

September 30, 2025

Via Stocktwits

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗

September 26, 2025

Via Benzinga

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗

September 22, 2025

Via Benzinga

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗

September 19, 2025

Via Investor's Business Daily

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Via Benzinga

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗

September 18, 2025

Via Investor's Business Daily

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots ↗

September 15, 2025

Via Benzinga

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects ↗

September 10, 2025

Via Benzinga

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? ↗

September 05, 2025

Via Investor's Business Daily

Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speed ↗

September 05, 2025

Via Benzinga

Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements ↗

September 04, 2025

Via Benzinga

Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' ↗

September 04, 2025

Via Benzinga

Frequently Asked Questions

Is Novavax, Inc. - Common Stock publicly traded?

Yes, Novavax, Inc. - Common Stock is publicly traded.

What exchange does Novavax, Inc. - Common Stock trade on?

Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Novavax, Inc. - Common Stock?

The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market

What is the current price of Novavax, Inc. - Common Stock?

The current price of Novavax, Inc. - Common Stock is 6.800

When was Novavax, Inc. - Common Stock last traded?

The last trade of Novavax, Inc. - Common Stock was at 12/23/25 04:00 PM ET

What is the market capitalization of Novavax, Inc. - Common Stock?

The market capitalization of Novavax, Inc. - Common Stock is 506.49M

How many shares of Novavax, Inc. - Common Stock are outstanding?

Novavax, Inc. - Common Stock has 506M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.